pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
1,486
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
RX-0301
Hepatocellular Carcinoma
Zhejiang Haichang Biotechnology Co Ltd
0
catalysts
Phase 2
RXRG-001
Xerostomia
RiboX (Shanghai) Therapeutics Co Ltd
0
catalysts
Phase 2
RY-104
Wet (Neovascular / Exudative) Macular Degeneration
Neuracle Genetics Inc
0
catalysts
Phase 2
RZ-001
Glioblastoma Multiforme (GBM)
← prev
page 24 of 50
next →
131
Pain
89
Neurology
1
Rznomics Inc
0
catalysts
Phase 2
Radspherin
Colorectal Cancer
Oncoinvent ASA
0
catalysts
Phase 2
Remygen
Type 1 Diabetes (Juvenile Diabetes)
Diamyd Medical AB
0
catalysts
Phase 2
ReversPAH
Pulmonary Arterial Hypertension
Artin Bioscience Inc
0
catalysts
Phase 2
RioDerm-001
Diabetic Foot Ulcers
Intent Biologics Inc
0
catalysts
Phase 2
Ruvembri
Sarcopenia
Biophytis SA
0
catalysts
Phase 2
S-309309
Obesity
$SGIOF
SHIONOGI & CO LTD
0
catalysts
Phase 2
S-337395
Respiratory Syncytial Virus (RSV) Infections
$SGIOF
SHIONOGI & CO LTD
0
catalysts
Phase 2
S-4V2
Bacillary Dysentery (Shigellosis)
$VALN
Valneva SE
0
catalysts
Phase 2
S-531011
Adenocarcinoma Of The Gastroesophageal Junction
$SGIOF
SHIONOGI & CO LTD
0
catalysts
Phase 2
SA-53
Dedifferentiated Liposarcoma
Lamassu Bio Inc
0
catalysts
Phase 2
SAB-142
Type 1 Diabetes (Juvenile Diabetes)
SAB BIO
0
catalysts
Phase 2
SAF-189
Non-Small Cell Lung Cancer
Fochon Pharmaceutical Ltd
0
catalysts
Phase 2
SAP-001
Gouty Arthritis (Gout)
Shanton Pharma Holdings Ltd
0
catalysts
Phase 2
SAR-402663
Wet (Neovascular / Exudative) Macular Degeneration
$SNY
Sanofi
0
catalysts
Phase 2
SAR-444836
Phenylketonuria (PKU)
$SNY
Sanofi
0
catalysts
Phase 2
SAR-446268
Myotonic Dystrophy
$SNY
Sanofi
0
catalysts
Phase 2
SAR-446597
Geographic Atrophy
$SNY
Sanofi
0
catalysts
Phase 2
SASS-001
Obstructive Sleep Apnea
Shionogi-Apnimed Sleep Science LLC
0
catalysts
Phase 2
SAT-3247
Duchenne Muscular Dystrophy
$MSLE
Satellos Bioscience Inc.
0
catalysts
Phase 2
SB-007
Juvenile Macular Degeneration (Stargardt Disease)
Splice Bio SL
0
catalysts
Phase 2
SB-11285
Cervical Cancer
invoX Pharma Ltd
0
catalysts
Phase 2
SB-207
berdazimer sodium
Genital Warts (Condylomata Acuminata)
$PTHS
Pelthos Therapeutics Inc.
0
catalysts
Phase 2
SCG-101
Hepatocellular Carcinoma
SCG Cell Therapy Pte Ltd
0
catalysts
Phase 2
SCIB-1
Metastatic Melanoma
Scancell Holdings Plc
0
catalysts
Phase 2
SCIB1 + iSCIB1+
Metastatic Melanoma
Scancell Holdings Plc
0
catalysts
Phase 2
SCP-776
Acute Ischemic Stroke
Silver Creek Pharmaceuticals Inc
0
catalysts